In the study conducted by researchers Ezelote, Nwoke, Ibe, and their team, the aim was to examine how mobile health technologies can serve as a vital tool in ensuring that individuals suffering from HIV/AIDS remain engaged in their healthcare routine. The significance of keeping regular appointments cannot be overstated; it is essential for routine monitoring, therapy adjustments, and prevention of disease progression. However, the challenge remains that many individuals miss these important appointments, leading to worse health outcomes.

This research presents an interesting perspective given that many health care systems face a major hurdle: ensuring patients stick to their treatment schedules. Factors contributing to missed appointments are varied, including stigma, transportation issues, forgetfulness, and a lack of motivation. By leveraging mobile health solutions, the study aimed to address some of these barriers and ascertain whether text reminders, appointment scheduling applications, or telehealth consultations could improve attendance rates.

In this particular study, participants were recruited from several selected hospitals in Owerri. The researchers employed a mixed-methods approach that encompassed both quantitative and qualitative components. Quantitatively, the study tracked the appointment attendance rates of participants before and after the implementation of the mobile health intervention. Qualitatively, interviews and focus groups provided deeper insights into the patient’s experience, barriers faced, and what motivates individuals to keep their appointments.

Initial findings indicated that the integration of mobile health interventions significantly increased the rates of clinic attendance among participants. Not only did this suggest efficacy in improving adherence, but it also pointed to the potential of technology to transform how care is delivered for chronic diseases like HIV/AIDS. The text reminders proved particularly effective, facilitating better communication between healthcare providers and patients. Participants noted that receiving reminders days before their appointments helped them prioritize their healthcare needs amidst daily responsibilities and life’s unpredictabilities.

Telehealth consultations further enhanced engagement, particularly for individuals who faced geographical or health-related constraints to attending in-person. The flexibility of scheduling virtual appointments allowed these individuals to maintain routine care without the barriers posed by physical distance or mobility issues. Such arrangements can lead to timely medication adjustments and immediate consultations for emerging health issues, ultimately promoting better health outcomes.

While the study’s results are promising, it also sheds light on the complexities of healthcare delivery in resource-limited settings. Recognizing that technological solutions do not exist in a vacuum is essential; surrounding infrastructure, digital literacy, and a comprehensive understanding of patients’ needs are fundamental to the successful adoption of mobile health interventions. Moreover, varying levels of access to mobile devices and internet connectivity within different demographics could affect the scalability of such programs.

The implications extend beyond individual patient care; they can influence public health policies at large. If mobile health interventions are proven to be effective, policymakers may consider investing in these technologies as part of comprehensive strategies to combat HIV/AIDS and similar chronic illnesses. Comprehensive integration of such technologies into healthcare systems could lead to a cultural shift toward proactive health management, paving the way for healthier communities.

Despite the clear benefits, challenges remain. Ethical concerns about data privacy and security cannot be overlooked. As mobile health systems often require personal health information to be transmitted electronically, safeguarding this information must be a priority. Equally important is the need for ongoing support for users; training programs may be necessary to ensure that patients can fully utilize these mobile health resources, particularly amongst older populations or those less familiar with technology.

Moreover, the commitment of healthcare workers to adapt their workflows to incorporate mobile health solutions remains paramount. As clinicians begin to rely on these interventions for better patient management, initiatives preparing healthcare staff to coexist with digital platforms could lead to a more streamlined healthcare experience for patients. Recognizing that health is a shared journey between providers and patients will be crucial in employing mobile health technologies effectively.

In conclusion, the study led by Ezelote and colleagues underscores the potential of mobile health interventions in enhancing clinic appointment adherence for people living with HIV/AIDS in Nigeria. As the world continues to contend with health crises exacerbated by access limitations, the role of technology must be acknowledged and harnessed as a means of empowerment. Through determined research, innovative practices, and policy support, there lies an opportunity to transform healthcare delivery for chronic diseases, ensuring that no individual is left behind in their pursuit of optimal health.

Subject of Research: The impact of mobile health intervention on keeping clinic appointments among people living with HIV/AIDS.

Article Title: The impact of a mobile health intervention on keeping clinic appointments among people living with HIV/AIDS receiving care at selected hospitals in Owerri, Imo State, Nigeria.

Article References:

Ezelote, C., Nwoke, E., Ibe, S. et al. The impact of a mobile health intervention on keeping clinic appointments among people living with HIV/AIDS receiving care at selected hospitals in Owerri, Imo State, Nigeria.
BMC Health Serv Res 25, 1354 (2025). https://doi.org/10.1186/s12913-025-13541-8

Image Credits: AI Generated

DOI: 10.1186/s12913-025-13541-8

Keywords: mobile health, HIV/AIDS, clinic appointments, health intervention, Nigeria.

Cancer continues to pose a significant public health challenge across the ASEAN member states, where demographic, socioeconomic, and infrastructural disparities influence health outcomes. Despite advances in medical technology, cancer screening programs vary widely in terms of their methodology, target populations, and screening intervals, illustrating a fragmented approach to what must be a coordinated effort to improve early detection. This patchwork of strategies often undermines the efficacy of early diagnosis, which is critical to improving survival rates.

The study, authored by Tun and colleagues, undertakes a thorough analysis of cancer screening frameworks throughout the ASEAN region, paying particular attention to how artificial intelligence is being utilized to enhance screening accuracy, efficiency, and ultimately, clinical outcomes. AI’s potential to revolutionize screening through advanced pattern recognition and predictive analytics could offer transformative benefits, especially in resource-limited settings prevalent in parts of Southeast Asia.

Leveraging PRISMA-ScR guidelines, the research team meticulously compiled data from government health ministries, official national cancer control guidelines, and peer-reviewed literature utilizing extensive database searches through PubMed, Scopus, and Google Scholar. The review specifically included studies conducted from 2019 to mid-2024, ensuring a contemporary overview of both traditional screening programs and cutting-edge AI applications. This rigor allows for an inclusive perspective that bridges policy, clinical practice, and emerging technology.

The findings reveal a stark dichotomy within ASEAN cancer screening protocols. Countries like Myanmar, Laos, Cambodia, Vietnam, Brunei, the Philippines, Indonesia, and Timor-Leste have primarily adopted opportunistic screening approaches. This model relies heavily on patient-initiated testing or incidental detection during unrelated healthcare visits, leading to inconsistent coverage and variable diagnostic yield. Conversely, more developed systems in Singapore, Malaysia, and Thailand demonstrate predominantly organized screening programs characterized by systematic population-wide invitations, standardized intervals, and data-driven follow-up mechanisms.

Cervical cancer screening emerges as the most widespread across both opportunistic and organized models, reflecting successful implementation of both Pap smear cytology and human papillomavirus (HPV) testing in several countries. Other cancers under active screening scrutiny include breast, colorectal, hepatic, lung, and oral cancers — with varying degrees of emphasis depending on local prevalence and resource availability.

Among the 14 studies included in the scoping review, breast cancer screening was the most frequently addressed, reflecting global trends given its high incidence and survival outcomes affected drastically by early detection. The researchers noted that AI’s integration into cancer screening workflows is in varying phases: half of the studies evaluated prospectively in clinical settings, over a third were silent trials where AI runs alongside human screening without affecting clinical decisions, and the remainder focused on exploratory model development aimed at future deployment.

AI applications ranged from image-based diagnostics, such as mammography and colonoscopy interpretation aided by deep learning algorithms, to predictive risk stratification models that customize screening intervals and protocols based on individualized patient data. The initial results demonstrate that AI not only improves sensitivity and specificity of cancer detection but also holds promise in reducing operational costs by automating labor-intensive tasks and minimizing unnecessary biopsies or follow-up procedures.

Despite these advances, the review underscores several persistent challenges. In many ASEAN countries, limited digital infrastructure, scarcity of high-quality annotated datasets for training AI models, and regulatory hurdles stall the full-scale deployment of AI-centric screening. Moreover, the heterogeneity of healthcare systems and sociocultural factors influence screening uptake and acceptance of AI interventions, highlighting the need for tailored implementation strategies.

The conclusion drawn from this comprehensive scoping review advocates for a shift towards more organized, standardized cancer screening programs aligned with the World Health Organization’s 2030 targets. Such programs must adopt regular screening intervals, prioritize appropriate age groups, and ensure equitable access across varied populations. Integrating AI technologies judiciously can catalyze this transformation by enabling precision medicine, facilitating early detection, and optimizing resource allocation.

Incorporating AI into cancer screening in countries like Singapore, Malaysia, Vietnam, Thailand, and Indonesia has already demonstrated promising enhancements in diagnostic accuracy and workflow efficiency. These implementations point towards a future where AI-supported screening could significantly reduce cancer-related mortality by enabling timely interventions supported by robust data analytics and machine learning.

The review also highlights the critical role of interdisciplinary collaboration spanning clinical experts, data scientists, policymakers, and international stakeholders to establish best-practice guidelines for AI integration. Robust validation studies, ethical frameworks addressing patient privacy, and capacity-building initiatives focusing on technical expertise will be vital components to scale AI innovations sustainably.

As ASEAN nations continue to grapple with the dual burden of communicable and noncommunicable diseases, advancing cancer screening through AI offers a beacon of hope. The synergy of emerging technology and strengthened public health infrastructure could unlock unprecedented potential in cancer prevention and control, driving progress towards healthier futures for millions.

While the transformative power of AI is evident, the path to widespread adoption remains complex and nuanced. Future research should focus on longitudinal, multicenter studies to understand real-world impact and guide policies for equitable AI deployment in diverse clinical settings. Additionally, patient and provider education will be critical to foster trust and acceptance of AI-assisted cancer screening paradigms.

The exploration of AI’s role in cancer screening within ASEAN is not merely a technological endeavor but a healthcare imperative reflective of regional needs and global ambitions. This scoping review lays a foundational roadmap for future innovations, emphasizing that technological progress must be accompanied by systems-level integration and ethical stewardship.

The compelling data and insights emerging from this research signify a paradigm shift where AI augments human expertise, amplifying the reach and efficacy of cancer screening programs. By closing existing gaps in early detection and enhancing diagnostic confidence, AI-enabled screening can become an integral pillar in the pursuit of cancer control across Southeast Asia and beyond.

In sum, the thoughtful convergence of digital intelligence with organized healthcare delivery is poised to redefine cancer screening landscapes. The ASEAN region stands at the cusp of this transformation, where informed policy, strategic investment, and collaborative innovation will determine the trajectory of cancer prevention for generations.

Subject of Research: Artificial intelligence application and evaluation in cancer screening programs across ASEAN countries.

Article Title: Artificial intelligence utilization in cancer screening program across ASEAN: a scoping review

Article References:
Tun, H.M., Rahman, H.A., Naing, L. et al. Artificial intelligence utilization in cancer screening program across ASEAN: a scoping review. BMC Cancer 25, 703 (2025). https://doi.org/10.1186/s12885-025-14026-x

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14026-x